Sex Differences in Cardiovascular Outcomes and Cholesterol-Lowering Efficacy of PCSK9 Inhibitors
2023 · JACC Advances · 26 citations
https://doi.org/10.1016/j.jacadv.2023.100669
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
115
Citations
7
h-index
3
i10-index
Sung Whoy is an academic researcher from Texas Tech University. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Cardiac Valve Diseases and Treatments & Atrial Fibrillation Management and Outcomes. The author has an h-index of 7, co-authored 24 publications.
ORCID: 0000-0002-2487-2802https://doi.org/10.1016/j.jacadv.2023.100669
https://doi.org/10.1016/j.ajpc.2024.100645
https://doi.org/10.6084/m9.figshare.24058572
Click to start Chat